Clinical Trial Update: The Effects of Dexmedetomidine and Remifentanil on Carotid Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating dexmedetomidine and remifentanil in patients with carotid artery stenosis was terminated, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carotid Artery Stenosis

Drugs mentioned

• PRECEDEX (DEXMEDETOMIDINE HYDROCHLORIDE)
• Ultiva (remifentanil)

Snippet

Sponsor: The Cleveland Clinic | Conditions: Carotid Artery Stenosis | Phase 4 | Status: TERMINATED | Results posted: 2017-08-11